164 related articles for article (PubMed ID: 36202075)
21. A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation.
Perkins MA; Osterhues MA; Farage MA; Robinson MK
Skin Res Technol; 2001 Nov; 7(4):227-37. PubMed ID: 11737818
[TBL] [Abstract][Full Text] [Related]
22. An Emerging Role of
Yang Y; Zhao Y; Lai R; Xian L; Lei Q; Xu J; Guo M; Xian D; Zhong J
Oxid Med Cell Longev; 2022; 2022():5800586. PubMed ID: 35720176
[TBL] [Abstract][Full Text] [Related]
23. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
24. IL-1β, IL-17A and combined phototherapy predicts higher while previous systemic biologic treatment predicts lower treatment response to etanercept in psoriasis patients.
Liu Y; Qin G; Meng Z; Du T; Wang X; Tang Y; Cao J
Inflammopharmacology; 2019 Feb; 27(1):57-66. PubMed ID: 30242748
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis.
Amarbayasgalan T; Takahashi H; Dekio I; Morita E
Int Arch Allergy Immunol; 2013; 160(1):63-74. PubMed ID: 22948248
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8.
Ameglio F; Bonifati C; Fazio M; Mussi A; Trento E; Cordial Fei P; Donati P; Pimpinelli F; D'Auria L; Carducci M
Arch Dermatol Res; 1997 Jun; 289(7):399-403. PubMed ID: 9248618
[TBL] [Abstract][Full Text] [Related]
27. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
[TBL] [Abstract][Full Text] [Related]
28. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
[TBL] [Abstract][Full Text] [Related]
29. Advancements in non-invasive skin sampling: Clinical conditions characterization via the assessment of skin surface cytokine biomarkers.
Portugal-Cohen M; Oron M; Cohen D; Ma'or Z; Soroka Y; Frusic-Zlotkin M; Kohen R
Exp Dermatol; 2024 Feb; 33(2):e15037. PubMed ID: 38389180
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous release of leukemia inhibitory factor and oncostatin-M is increased in supernatants of short-term organ cultures from lesional psoriatic skin.
Bonifati C; Mussi A; D'Auria L; Carducci M; Trento E; Cordiali-Fei P; Ameglio F
Arch Dermatol Res; 1998; 290(1-2):9-13. PubMed ID: 9522995
[TBL] [Abstract][Full Text] [Related]
31. The expression of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in psoriasis skin.
Chen X; Tan Z; Yue Q; Liu H; Liu Z; Li J
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):750-2. PubMed ID: 17357509
[TBL] [Abstract][Full Text] [Related]
32. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.
Watanabe Y; Yamaguchi Y; Komitsu N; Ohta S; Azuma Y; Izuhara K; Aihara M
Br J Dermatol; 2016 Jun; 174(6):1327-36. PubMed ID: 26822223
[TBL] [Abstract][Full Text] [Related]
33. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.
Szegedi K; Lutter R; Res PC; Bos JD; Luiten RM; Kezic S; Middelkamp-Hup MA
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2136-44. PubMed ID: 25980674
[TBL] [Abstract][Full Text] [Related]
34. The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity.
Wu LT; Qiao ZH; Tian JB; Lin JL; Hou SC; Liu XM
Skin Res Technol; 2023 Jul; 29(7):e13405. PubMed ID: 37522491
[TBL] [Abstract][Full Text] [Related]
35. Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.
Clausen ML; Jungersted JM; Andersen PS; Slotved HC; Krogfelt KA; Agner T
Br J Dermatol; 2013 Sep; 169(3):587-93. PubMed ID: 23647067
[TBL] [Abstract][Full Text] [Related]
36. Assessing the severity of psoriasis through multivariate analysis of optical images from non-lesional skin.
Žurauskas M; Barkalifa R; Alex A; Marjanovic M; Spillman DR; Mukherjee P; Neitzel CD; Lee W; Medler J; Arp Z; Cleveland M; Hood S; Boppart SA
Sci Rep; 2020 Jun; 10(1):9154. PubMed ID: 32513976
[TBL] [Abstract][Full Text] [Related]
37. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1: a key inflammatory mediator in psoriasis?
Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
[TBL] [Abstract][Full Text] [Related]
39. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
[TBL] [Abstract][Full Text] [Related]
40. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.
Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O
PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
